Stock MTEM MOLECULAR TEMPLATES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Molecular Templates, Inc.

Equities

MTEM

US6085502085

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.705 USD +6.56% Intraday chart for Molecular Templates, Inc. +15.99% -54.29%
Apr. 12 Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024 CI
Apr. 09 Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting CI

Evolution of the average Target Price on Molecular Templates, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f8c8634ccb60b2d3f8c3d06d0.2F0rDG_fFMPKU08GhPd6ipvVuUZlLvO5YNE0-uNOhSk.iScefCSRde78P3xL3q810KyP7zdVGIKNK6hlmZk-5Bm3G3JLPKUt8oZkFg~17f33633f410afc890fdc7bda0e29177

Analyst Recommendations on Molecular Templates, Inc.

Barclays Adjusts Price Target on Molecular Templates to $1 From $4.50, Maintains Overweight Rating MT
Stifel Nicolaus Adjusts Molecular Templates Price Target to $5 From $9, Maintains Buy Rating MT
BofA Securities Downgrades Molecular Templates to Underperform From Buy, Sets Price Target at $1.50 MT
Stifel Adjusts Molecular Templates' Price Target to $9 From $11, Reiterates Buy Rating MT
Barclays Adjusts Molecular Templates' Price Target to $4.50 from $8, Keeps Overweight Rating MT
Oppenheimer Lowers Price Target for Molecular Templates to $9 From $13, Maintains Outperform Rating MT
MOLECULAR TEMPLATES : UBS Adjusts PT on Molecular Templates to $8 From $13 on MT-3724 Discontinuation, TAK-169 Rights Reversion, MT-6402 Program Start; Neutral Rating Kept MT
MOLECULAR TEMPLATES : BofA Securities Starts Molecular Templates at Buy with $12 Price Target MT
MOLECULAR TEMPLATES : Oppenheimer Adjusts Molecular Templates' Price Target to $13 From $18, Maintains Outperform Rating MT
MOLECULAR TEMPLATES : UBS Starts Molecular Templates at Neutral With $13 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.705 USD
Average target price
18 USD
Spread / Average Target
+955.72%
High Price Target
18 USD
Spread / Highest target
+955.72%
Low Price Target
18 USD
Spread / Lowest Target
+955.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Molecular Templates, Inc.

Barclays
Stifel Nicolaus
BofA Securities
Oppenheimer
UBS

Ratings for Molecular Templates, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MTEM Stock
  4. Consensus Molecular Templates, Inc.